WELIREG Treatment Resources
Merck
The WELIREG Treatment Resources page provides various patient support materials and directs patients to external third-party organizations for help with daily challenges. While these external resources may offer assistance with housing, food, and transportation, the WELIREG program itself does not explicitly provide direct financial grants for travel assistance.
- Covers
- hotelsmealstransportationfinancial assistance
- Enrollment cycle
- unknown
Eligibility
Eligibility is for adults with advanced clear cell renal cell carcinoma (RCC) who have previously been treated with a PD-1/PD-L1 inhibitor and a VEGF-TKI. The program provides links to third-party resources that may assist with daily challenges such as transportation, housing, and food.
Apply
Application goes directly to Merck. RxCopays does not receive compensation.
Go to application →Status source
Resources for WELIREG ® (belzutifan) patients
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: